| Literature DB >> 31694690 |
Guoqing Li1,2, Jian Weng1,2, Chang Xu1,2, Deli Wang1,2, Ao Xiong1,2, Hui Zeng3,4.
Abstract
OBJECTIVES: The purpose of this study is to identify the factors that influence the length of stay (LOS) in total knee arthroplasty (TKA) patients with an enhanced recovery after surgery (ERAS) program.Entities:
Keywords: Enhanced recovery after surgery; Factors; Length of stay; Total knee arthroplasty
Mesh:
Year: 2019 PMID: 31694690 PMCID: PMC6836496 DOI: 10.1186/s13018-019-1389-1
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Fig. 1Flowchart that illustrates patients excluded from the study
Single-factor chi-square analysis of the demographic characteristics (N = 167)
| Factors | Classification | Number | Percent | Mean ± SD | ||
|---|---|---|---|---|---|---|
| Gender | Female | 136 | 81.4 | 19.24 ± 6.72 | 0.275 | 0.601 |
| Male | 31 | 18.60 | 18.55 ± 6.37 | |||
| Age (year) | Y < 50 | 6 | 3.60 | 19.83 ± 3.60 | 0.540 | 0.706 |
| 50 ≤ Y < 60 | 22 | 13.20 | 19.09 ± 4.51 | |||
| 60 ≤ Y < 70 | 74 | 44.30 | 18.32 ± 7.25 | |||
| 70 ≤ Y < 80 | 53 | 31.70 | 20.02 ± 6.45 | |||
| 80 ≤ Y | 12 | 7.20 | 19.67 ± 8.15 | |||
| BMI (kg/m2) | BMI < 18.5 | 3 | 1.80 | 19.67 ± 5.51 | 0.620 | 0.685 |
| 18.5 ≤ BMI < 24 | 59 | 35.30 | 19.05 ± 7.08 | |||
| 24 ≤ BMI < 28 | 63 | 37.70 | 19.49 ± 7.17 | |||
| 28 ≤ BMI < 30 | 20 | 12.00 | 17.65 ± 5.32 | |||
| 30 ≤ BMI < 40 | 19 | 11.40 | 18.68 ± 2.89 | |||
| 40 ≤ BMI | 3 | 1.80 | 24.33 ± 13.01 |
BMI body mass index
Single-factor chi-square analysis of preoperative variables (N = 167)
| Factors | Classification | Number | Percent | Mean ± SD | ||
|---|---|---|---|---|---|---|
| Pre-operation Hb (g/L) | Hb < 100 | 5 | 3.00 | 20.00 ± 5.79 | 5.457 | 0.104 |
| 100 ≤ Hb < 110 | 13 | 7.80 | 22.08 ± 10.17 | |||
| 110 ≤ Hb < 120 | 23 | 13.80 | 21.74 ± 7.09 | |||
| 120 ≤ Hb < 130 | 52 | 31.10 | 17.29 ± 4.68 | |||
| 130 ≤ Hb < 140 | 46 | 27.50 | 18.87 ± 7.60 | |||
| 140 ≤ Hb | 28 | 16.80 | 19.21 ± 4.98 | |||
| Pre-operation albumin (g/L) | < 30 | 2 | 1.20 | 33.50 ± 4.95 | 4.675 | 0.002 |
| ≥ 30 | 165 | 98.80 | 18.94 ± 6.48 | |||
| Pre-operation ESR (mm/h) | < 15 | 77 | 46.10 | 17.71 ± 5.22 | 6.560 | 0.011 |
| ≥ 15 | 90 | 53.90 | 20.31 ± 7.47 | |||
| Pre-operation CRP (mg/L) | < 5 | 44 | 26.30 | 18.55 ± 6.48 | 0.371 | 0.691 |
| ≥ 5 | 122 | 73.70 | 19.29 ± 6.73 | |||
| Primary disease | RA | 16 | 9.60 | 23.50 ± 7.80 | 8.050 | 0.005 |
| OA | 151 | 90.40 | 18.65 ± 6.36 | |||
| Merge disease | No | 112 | 67.10 | 18.36 ± 5.96 | 4.509 | 0.035 |
| Yes | 55 | 32.90 | 20.65 ± 7.68 | |||
| ASA class | 1 | 38 | 22.80 | 16.61 ± 5.17 | 3.844 | 0.023 |
| 2 | 120 | 71.90 | 19.75 ± 6.53 | |||
| 3 | 9 | 5.40 | 21.22 ± 10.76 |
Hb hemoglobin, ESR erythrocyte sedimentation, CRP C-reactive protein, ASA American Society of Anesthesiologists
Single-factor chi-square analysis of operational variables (N = 167)
| Factors | Classification | Number | Percent | Mean ± SD | ||
|---|---|---|---|---|---|---|
| Hidden blood loss (△Hb) (g/L) | △Hb < 10 | 30 | 18.00 | 19.30 ± 6.56 | 2.729 | 0.031 |
| 10 ≤ △Hb < 20 | 56 | 33.50 | 20.77 ± 8.23 | |||
| 20 ≤ △Hb < 30 | 43 | 25.70 | 17.84 ± 4.54 | |||
| 30 ≤ △Hb < 40 | 32 | 19.20 | 18.94 ± 5.55 | |||
| 40 ≤ △Hb | 6 | 3.60 | 12.83 ± 3.66 | |||
| Surgery begins | < 14:00 P.M. | 53 | 31.70 | 18.86 ± 6.60 | 0.525 | 0.470 |
| ≥ 14:00 P.M. | 114 | 68.30 | 19.66 ± 6.75 | |||
| Op-duration T (h) | T < 2 | 24 | 13.50 | 17.92 ± 3.96 | 4.524 | 0.002 |
| 2 ≤ T < 3 | 97 | 55.90 | 18.38 ± 5.49 | |||
| 3 ≤ T < 4 | 35 | 25.20 | 23.00 ± 9.78 | |||
| 4 ≤ T < 5 | 3 | 1.40 | 15.33 ± 2.08 | |||
| 5 ≤ T | 8 | 4.00 | 16.00 ± 3.21 | |||
| Transfusion | No | 152 | 91.00 | 18.82 ± 6.15 | 2.682 | 0.071 |
| Yes | 15 | 9.00 | 22.07 ± 10.25 | |||
| Urine tube | No | 33 | 19.80 | 17.70 ± 6.46 | 1.882 | 0.172 |
| Yes | 134 | 80.20 | 19.46 ± 6.67 | |||
| Drainage | No | 147 | 88.00 | 19.09 ± 6.56 | 8.345 | 0.894 |
| Yes | 20 | 12.00 | 19.30 ± 7.36 | |||
| Tourniquet | No | 2 | 1.20 | 12.50 ± 3.54 | 2.021 | 0.157 |
| Yes | 165 | 98.80 | 19.19 ± 6.63 |
Fig. 2Regression curves
Multi-factor linear regression analysis (N = 167)
| Factors | 95%CI | ||||
|---|---|---|---|---|---|
| Gender ( | |||||
| Female | (Control group) | ||||
| Male | − 3.56 | 1.58 | − 2.25 | 0.03 | − 6.69~− 0.42 |
| Age ( | |||||
| Y < 50 | (Control group) | ||||
| 50 ≤ Y < 60 | 2.80 | 3.30 | 0.85 | 0.40 | − 3.72~9.34 |
| 60 ≤ Y < 70 | 0.26 | 3.33 | 0.08 | 0.94 | − 6.32~6.86 |
| 70 ≤ Y < 80 | − 0.82 | 3.36 | − 0.24 | 0.81 | − 7.46~5.83 |
| 80 ≤ Y | − 0.67 | 3.88 | − 0.17 | 0.86 | − 8.35~7.01 |
| ASA class ( | |||||
| 1 | (Control group) | ||||
| 2 | 2.49 | 1.36 | 1.83 | 0.07 | − 0.21~5.18 |
| 3 | 4.84 | 2.51 | 1.92 | 0.049 | − 0.14~9.81 |
| Duration T ( | |||||
| T < 2H | (Control group) | ||||
| 2H ≤ T < 3H | 1.07 | 2.13 | 0.50 | 0.62 | − 3.16~5.29 |
| 2H ≤ T < 3H | 8.09 | 2.86 | 2.84 | 0.005 | 2.44~13.74 |
| 4H ≤ T < 5H | 5.26 | 6.61 | 0.80 | 0.43 | − 7.83~18.35 |
| T ≥ 5H | 4.71 | 5.74 | 0.82 | 0.41 | − 6.67~16.09 |
| Pre-operation albumin ( | |||||
| ≥ 30 g/L | (Control group) | ||||
| < 30 g/L | 18.33 | 5.41 | 3.39 | 0.001 | 7.61~29.05 |
| Pre-operation ESR ( | |||||
| < 15 mmol/h | (Control group) | ||||
| ≥ 15 mmol/h | 2.21 | 1.01 | 2.18 | 0.03 | 0.21~4.22 |
| Primary disease ( | |||||
| KOA | (Control group) | ||||
| KRA | − 3.04 | 2.15 | − 1.42 | 0.16 | − 7.30~1.21 |
| Merge disease ( | |||||
| No | (Control group) | ||||
| Yes | 1.97 | 1.12 | 1.76 | 0.08 | − 0.54~2.92 |
| Tourniquet ( | |||||
| No | (Control group) | ||||
| Yes | 8.60 | 4.58 | 1.88 | 0.06 | − 0.48~17.68 |
ASA American Society of Anesthesiologists, ESR erythrocyte sedimentation, KOA knee osteoarthritis, KRA knee rheumatoid arthritis